Lean PCOS: When You Don't Match the Stereotype

If you have irregular cycles, some androgen symptoms, and a normal weight, you have probably been told for years that you do not look like PCOS. That sentence is wrong, and the data has known it is wrong for at least a decade. This post is for readers asking how to know if you have PCOS when the stereotype does not fit, and for those who want to walk back into the appointment with the actual evidence.

Lean PCOS is not a separate diagnosis. The 2023 international PCOS guideline uses the same Rotterdam criteria regardless of weight: two of three features from oligo-ovulation, hyperandrogenism, or polycystic ovarian morphology (or elevated AMH), with other causes ruled out.¹ What changes at a lower BMI is not the diagnostic threshold; it is the clinician's likelihood of looking for the diagnosis in the first place, and that gap is what gets readers missed for years.

How to know if you have PCOS at a normal BMI

Lean PCOS is shorthand for PCOS in someone with a BMI under 25 (or under 23 in some Asian populations, following the WHO Asia-Pacific cutoff). About 20 to 30 percent of people with PCOS sit in this BMI range, depending on the population studied and how thoroughly the diagnosis is pursued.²,⁴ The systematic review by Lim and colleagues mapped the BMI distribution across PCOS populations and found a meaningful normal-weight minority in every dataset.⁴

What lean PCOS does not mean: it does not mean a milder version of PCOS, it does not mean the metabolic warnings do not apply, and it does not mean the diagnostic workup should be shorter. The Stepto group used the gold-standard euglycaemic-hyperinsulinaemic clamp to show that intrinsic insulin resistance is present in PCOS at normal weight, independent of body composition.⁵ In other words, you can be lean and still have the insulin signalling problem at the centre of the syndrome.

BMI is a screening shortcut, not a phenotype. Central adiposity and metabolic risk can both exist at a normal BMI, and a dexa scan or a waist circumference will sometimes flag a metabolic picture that the BMI hides.

Why lean PCOS gets missed

Several things conspire to keep this diagnosis hidden:

• The mental model many clinicians were trained on is the textbook image of PCOS as "obese, hirsute, anovulatory." That bias persists in current practice, despite being out of date.²
• Lean PCOS often has milder hirsutism scores, especially in East and Southeast Asian populations, where the Ferriman-Gallwey scale systematically underestimates androgen excess.
• Cycles in lean PCOS are often only mildly irregular (35 to 45 days rather than dramatically anovulatory), so the cycle history reads as "a bit irregular" rather than alarming.
• Insulin resistance can be present without the visible markers. No acanthosis nigricans, normal fasting glucose, a perfectly reasonable lipid panel on the surface.²
• A normal-looking ultrasound on a low-frequency or transabdominal probe will under-count follicles, and the report may not flag the polycystic morphology that a high-frequency transvaginal scan would have caught. See PCOS on Ultrasound: What Doctors Actually See for the probe-frequency detail.

Put together, the result is a person who fits the diagnostic pattern but gets reassured at every visit. The fix is to insist on the full Rotterdam workup, exactly as it would be done at a higher BMI.

What the workup should still include

A complete workup, regardless of BMI, per the 2023 guideline:¹

• Full Rotterdam assessment applying the same two-of-three rule.
• Full hormone panel: FSH, LH, total and free testosterone, SHBG, DHEAS, 17-hydroxyprogesterone, AMH, prolactin, TSH. See The PCOS Blood Test Panel.
• Transvaginal ultrasound with a high-frequency (≥ 8 MHz) probe, in the early follicular phase, off hormonal contraception for at least three months.
• A 2-hour oral glucose tolerance test. The 2023 guideline recommends OGTT in all adults with PCOS, regardless of weight. Fasting glucose alone misses early insulin resistance.¹
• Fasting lipid panel, blood pressure, and waist circumference. Standard cardiometabolic screen.

If your clinician orders only fasting glucose and skips the OGTT because your BMI is normal, that is a deviation from the 2023 guideline. The OGTT recommendation is BMI-independent.

How lean PCOS reads on the panel

The numbers tend to look slightly different in lean PCOS compared with higher-BMI PCOS:

• AMH is often elevated to a similar degree, because the follicle pool size is comparable across the BMI range.
• SHBG is typically higher in lean PCOS than in higher-BMI PCOS. Insulin suppresses SHBG production by the liver, so when insulin is lower, SHBG sits higher. The practical consequence is that total testosterone can look in the normal range while the free fraction (calculated via the free androgen index) is elevated. Always ask for SHBG with total testosterone, and always ask for the FAI calculation.
• Fasting glucose is often normal. The 2-hour OGTT value, or the 1-hour insulin value, is where the resistance shows up.
• LH:FSH ratio can be elevated more often, because there is less obesity-driven LH suppression in lean PCOS.
• Lipids can look reassuring on the standard panel while small-dense LDL or triglyceride-to-HDL ratio tells a different story. A standard panel does not always catch this.

These are tendencies, not rules. The point is that interpreting the panel in the same way as for higher-BMI PCOS, without these adjustments, is what causes lean readers to be told their numbers are fine.

Phenotypes in lean PCOS

The four Rotterdam phenotypes (A, B, C, D) apply regardless of BMI. The pillar post explains them in detail: How PCOS Is Diagnosed: The Rotterdam Criteria Explained.

In practice, the distribution shifts slightly in lean PCOS. Phenotype D (anovulation plus polycystic morphology, no hyperandrogenism) is more common in this group and carries the lowest metabolic risk of the four phenotypes. But phenotypes A and B still occur at normal BMI, and when they do, insulin resistance is still present. The Stepto clamp data is the clearest evidence that the resistance is intrinsic to the syndrome, not a consequence of weight.⁵ Do not let a clinician skip the OGTT because your phenotype "looks mild."

What does and does not change in management

Several things stay the same in lean PCOS:

• Letrozole remains first-line for ovulation induction. The treatment pathway in the Medicated Cycles hub applies.
• Inositol and metformin can still help with insulin signalling and ovulation, though effect sizes tend to be smaller at lower BMI. Discuss with your clinician.
• CoQ10 for egg quality, prenatal vitamins, and the rest of the preconception nutrition framework apply equally.

The thing that meaningfully changes in lean PCOS is the lifestyle prescription. Weight loss is not the answer. Restrictive eating advice from clinicians who default to "lose 5 to 10 percent of your body weight" is harmful in this group, both because the underlying physiology is not weight-driven and because under-fuelling at a normal BMI can push someone into functional hypothalamic amenorrhoea, which makes the original problem worse.

Strength training and adequate protein intake matter more in this phenotype than caloric restriction. Building muscle mass increases insulin sensitivity directly, independent of fat loss, and provides a metabolic buffer that lean PCOS often lacks. The Toosy review on lean PCOS describes this approach in detail.² If your clinician does not have an exercise prescription beyond "more cardio," that is a gap worth flagging.

What to push back on at the appointment

Five sentences I hear from readers regularly, and how to respond to each:

1. "You don't look like you have PCOS." Ask for the full Rotterdam workup anyway, citing the 2023 international guideline.
2. "Your fasting glucose is fine, so you don't have insulin resistance." Ask for a 2-hour OGTT. The guideline recommends it in all adults with PCOS regardless of BMI.¹
3. "Just lose 5 percent of your body weight." This does not apply at BMI under 25, and is potentially harmful. Ask for a different management plan.
4. "Come back when you're ready to conceive." If your cycles are irregular and you are trying or planning to try, the workup should not wait. Delayed diagnosis correlates with longer time to conception.
5. "Your testosterone is normal." Ask whether SHBG was drawn, and whether the free androgen index was calculated. Total T can look normal in lean PCOS while free androgens are elevated.

You can say all of this politely. None of it is unreasonable to ask. If the conversation does not move, Getting a Second Opinion on Your Fertility Workup walks through what a second-opinion visit can look like.

What to do this week

Three practical steps:

1. Make a list of every PCOS workup test you have had to date, with dates and cycle days, and check it against the panel in The PCOS Blood Test Panel. The most common gap I see in lean PCOS is missing SHBG, missing AMH, or fasting glucose without an OGTT.
2. If you have had an ultrasound, check whether it was transvaginal and whether the probe was 8 MHz or higher. If not, that scan does not meet the 2023 morphology criterion.
3. If your next appointment is more than a month away, ask whether bloods and a scan can be booked in the meantime, so the conversation can be about results rather than ordering.

What's next

• For the diagnostic framework, the pillar is How PCOS Is Diagnosed: The Rotterdam Criteria Explained.
• For the panel that should have been drawn regardless of BMI, read The PCOS Blood Test Panel: What Each Number Means.
• For the imaging side, read PCOS on Ultrasound: What Doctors Actually See.
• If a clinician dismissed your symptoms and you want a fresh read, see Getting a Second Opinion on Your Fertility Workup.
• For nutrition and supplement choices that fit this phenotype rather than the high-BMI default, read PCOS Diet and Fertility and Myo-Inositol for PCOS.

Sources

1. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025
2. Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. Journal of Diabetes & Metabolic Disorders 2018;17:277–285. https://doi.org/10.1007/s40200-018-0371-5
3. Goyal M, Dawood AS. Debates regarding lean patients with polycystic ovary syndrome: A narrative review. Journal of Human Reproductive Sciences 2017;10(3):154–161. https://doi.org/10.4103/jhrs.JHRS_77_17
4. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 2012;18(6):618–637. https://doi.org/10.1093/humupd/dms030
5. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulinaemic clamp. Human Reproduction 2013;28(3):777–784. https://doi.org/10.1093/humrep/des463